Tirzepatide can be a powerful tool for sustainable weight loss, but the medication is only half of the equation
SURMOUNT-1 (N=2,539) showed 20.9% mean weight loss at 72 weeks with the 15 mg dose [2]
Ataei Ataabadi, E
That is reassuring, but it does not eliminate the need for protein, progressive resistance training, and monitoring
Therapeutic strategies can therefore be envisioned to increase choroidal neuroprotective functions in perinatal conditions in which choroidal detoxifying systems may be sub-optimal, or when the brain is facing adverse oxidative and chemical stresses, such as exposure to pharmacological agents or environmental toxicants, hypoxia, and hyperbilirubinemia
In preclinical research, GH and IGF-1 are themselves anabolic and regenerative factors, suggesting potential complementarity